
Outlier Biopharma: A biotech firm specializing in R&D, manufacturing, and distribution of cannabis-based products.
Outlier Biopharma, founded with a mission to advance the science and application of cannabis and cannabinoid-based products, is a vertically integrated biotechnology company. Their core vision is to lead in the research, development, manufacturing, and distribution of high-quality cannabis products. They offer a comprehensive suite of services including outsourced consulting, contract cultivation, extraction, manufacturing, and advisory services, targeting both B2B and B2C markets.
Notable figures associated with Outlier Biopharma include industry experts in biotechnology and cannabis research. The company has achieved significant milestones in developing state-of-the-art facilities for processing and manufacturing, which have enabled them to provide top-tier private-label manufacturing services. Their impact is evident in their ability to help partners maximize profitability through efficient and innovative cannabis product solutions.

Hemp Synergistics

Next Frontier Biosciences

Open Book Extracts

Biopharmaceutical Research

Diverse Biotech

Harvest Direct Enterprises

Outpost Medicine

Skye Bioscience

Central Processors

Cannformatics
cannformatics.com

Franklin Group

Verda Bio
verdabio.com

Juva Life
juvalife.com

Emerald Health Pharmaceuticals

Applied Biosciences
Companies similar to Outlier Biopharma include Hemp Synergistics, Next Frontier Biosciences, Open Book Extracts and Biopharmaceutical Research.
Outlier Biopharma was founded in 2016.
Outlier Biopharma's headquarters is located in Cambridge, MA, US.
Outlier Biopharma's most recent funding round was for $750k (USD) in November 2016.
As of Nov 14, 2016, Outlier Biopharma has raised a total of $750k (USD).
Outlier Biopharma has 30 employees as of Feb 5, 2024.